Alcohol, lipid metabolism and body weight;Alkohol, fettstoffwechsel und körpergewicht

Therapeutische Umschau

Volumn 57, Issue 4, 2000, Pages 205-211

  Suter, P M ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN;

ALCOHOL LIVER DISEASE; ALCOHOLISM; BLOOD; BODY WEIGHT; DRINKING BEHAVIOR; HUMAN; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR;

ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; BODY WEIGHT; CHOLESTEROL, HDL; HUMANS; LIPIDS; LIPOPROTEINS; LIVER DISEASES, ALCOHOLIC; OBESITY; RISK FACTORS;

EID: 3042933362     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.57.4.205     Document Type: Article

References (32)

1. Tremblay A, St.Pierre S. The hyperphagic effect of a high-fat diet and alcohol intake persists after control for energy density. Am J Clin Nutr 1996; 63: 479-82.
2. Lieber CS, Jones DP, DeCarli LM. Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J Clin Invest 1965; 44: 1009-21.
3. Suter PM, Schutz Y, Jéquier E. The effect of ethanol on fat storage in healthy subjects. N Engl J Med 1992; 326(15): 983-7.
4. Siler SQ, Neese RA, Parks EJ Hellerstein MK. VLDL-triglyceride production after alcohol ingestion, studied using [2-13C1] glycerol. J Lipid Res 1998; 39: 2319-28.
5. Hartung GH, Foreyt JP, Reevers RS et al. Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active men. Metabolism 1990; 39: 81-6.
6. Santamarina-Fojo S, Brewer HB. Lipoproteinlipase: structure, function and mechanism of action. Int J Clin Lab Res 1994; 24: 143-7.
7. Chait A, Brunzell JD. Chylomicronemia syndrome. Adv Intern Med 1992; 37: 249-73.
8. Taskinen MR, Nikkilä EA. Nocturnal Hypertriglyceridemia and Hyperinsulinemia Following Moderate Evening Intake of Alcohol. Acta Med Scand 1977; 202: 173-7.
9. Pownall HJ, Ballantyne CM, Kimball KT et al. Effect of moderate alcohol consumption on hypertriglyceridemia. Arch Intern Med 1999; 159: 981-7.
10. Watts GF, Riches FM, Kelly JM, Powell MA, Croft KD. Determinants of kinetics of very low-density lipoprotein apolipoprotein B-100 in non-obese men. Clin Exp Pharmacol Physiol 1997; 24: 556-62.
11. Austin AM. Plasma triglyceride as a risk factor for coronary heart disease. Am J Epidemiol 1989; 129: 249-59.
12. Suter PM, Gerritsen Zehnder M, Häsler E et al. Effect of alcohol on postprandial lipemia with and without preprandial exercise. (in press), 1999.
13. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994; 272: 929-33.
14. Locher R, Suter PM Vetter W. Ethanol suppresses smooth muscle cell proliferation in the postprandial state: a new antiatherosclerotic mechanism of ethanol? Am J Clin Nutr 1998; 67: 338-41.
15. Suh I, Shaten B, Cutler JA J, Kuller LH. Alcohol use and mortality form coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med 1992; 116: 881-7.
16. Van de Wiel A. Alcohol and insulin sensitivity. Netherl J Med 1998; 52: 91-4.
17. Nishiwaki M, Ishikawa T, Ito T et al. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin:cholesterol acyltransferase in high density lipoprotein cholesterol elevation. Atherosclerosis 1994; 111: 99-109.
18. Williams PT. Interactive effects of exercise, alcohol, and vegetarian diet on coronary artery disease risk factors in 9242 runners: The National Runners' Health Study. Am J Clin Nutr 1997; 66: 1197-206.
19. Stein JH, Rosenson RS. Lipoprotein Lp (a) excess and coronary heart disease. Arch Intern Med 1997; 157: 1170-6.
20. Sharpe PC, Young IS, Evans AE. Effect of moderate alcohol consumption on 1p(a) lipoprotein concentrations. Reduction is supported by other studies. BMJ 1998; 316: 1675.
21. Braeckman L, De-bacquer D, Rosseneu M, De Backer G. Determinants of lipoprotein (a) levels in a middle-aged working population. Eur Heart J 1996; 17: 1808-13.
22. Bovet P, Rickenback M, Wietlisbach V et al. Comparison of serum lipoprotein (a) distribution and its correlates among black and white populations. Int J Epidemiol 1994; 23: 20-7.
23. Newsome WH, Rattray JBM. The enzymatic esterification of ethanol with fatty acids. Can J Biochem 1965;43: 1223-33.
24. Laposata EA, Lange LG. Presence of nonoxodative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 1986; 231: 497-9.
25. Beckemeier ME, Bora PS. Fatty acid ethyl esters: potentially toxic products of myocardial ethanol metabolism. J Mol Cell Cardiol 1998; 30: 2487-94.
26. Soderberg BL, Sicinska ET, Blodget E et al. Refinement of an assay for fatty acid ethyl ester in serum and plasma as an indicator of ethanol intake. Clin Chem. 1999; 45: 2183-2190.
27. Suter PM, Häsler E, Vetter W. Hypertonie und koronare Herzkrankheit. Globale Risikomodulation durch Kontrolle des Körpergewichts. Schw Rundschau Med (PRAXIS) 1996; 85: 113-6.
28. Ravussin E, Fontvieille AM, Swinburn BA, Bogardus C. Risk factors for the development of obesity. Ann NY Acad Sci 1993; 683: 141-50.
29. Suter PM, Häsler E, Vetter W. Effects of alcohol on energy metabolism and body weight regulation: Is alcohol a risk factor for obesity? Nutr Reviews 1997; 55: 157-171.
30. Suter PM, Jéquier E, Schutz Y. The effect of ethanol on energy expenditure. Am J of Physiol 1994; 266: R1204-R1212.
31. Suter PM, Maire R. Vetter W. Is an increased waist:hip ratio the cause of alcohol-induced hypertension. The AIR94 study. J Hypertens 1995; 13: 1857-62.
32. Suter PM, Häsler E, Meyer R, Vetter W. Modulation of the alcohol effects on body weight by the family history of overweight. Int J Obesity 1999; 23 (Supplement 5): S94.